Therefore, targeting P-gp represents another promising therapeutic alternative for AD treatment, as enhancing its expression or activity could increase the clearance of Aβ from the brain across the BBB, reducing its accumulation and ameliorating AD symptoms. The gene discussed is PGP; the disease is Alzheimer disease.